Abstract
Tricuspid valve structure and function are clinically relevant in a wide range of conditions. An accurate appreciation of the tricuspid valve by 2D and 3D echocardiography is critical to understanding pathologies that underlie these conditions. There can be significant variation in leaflet anatomy and one view alone may be limited or suboptimal, so it is important to assess leaflet anatomy in multiple views or consider additional imaging modalities when assessing the tricuspid valve. Echocardiography should be the first step in determining whether tricuspid regurgitation is primary, a condition due to abnormal leaflets, or secondary, a result of structural changes to the right ventricle or the tricuspid annulus or valve apparatus. The ability to grade tricuspid regurgitation severity relies not just on color Doppler but also on the use of hemodynamics, which can be obtained from a variety of echocardiographic indices. A new gradation scheme for assessing the severity of tricuspid regurgitation has been recently proposed using these indices. Finally, echocardiography allows for decision-making for percutaneous or surgical interventions and allows for both pre-procedural planning and intra-procedural guidance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hahn RT, Waxman AB, Denti P, Delhaas T. Anatomic relationship of the complex tricuspid valve, right ventricle, and pulmonary vasculature: a review. JAMA Cardiol. 2019;4(5):478–87.
Muraru D, Hahn RT, Soliman OI, Faletra FF, Basso C, Badano LP. 3-dimensional echocardiography in imaging the tricuspid valve. JACC Cardiovasc Imaging. 2019;12(3):500–15.
Khalique OK, Cavalcante JL, Shah D, Guta AC, Zhan Y, Piazza N, et al. Multimodality imaging of the tricuspid valve and right heart anatomy. JACC Cardiovasc Imaging. 2019;12(3):516–31.
Addetia K, Yamat M, Mediratta A, Medvedofsky D, Patel M, Ferrara P, et al. Comprehensive two-dimensional interrogation of the tricuspid valve using knowledge derived from three-dimensional echocardiography. J Am Soc Echocardiogr. 2016;29(1):74–82.
Hahn RT. State-of-the-art review of echocardiographic imaging in the evaluation and treatment of functional tricuspid regurgitation. Circ Cardiovas Imaging. 2016;9(12):e005332.
Taramasso M, Gavazzoni M, Pozzoli A, Dreyfus GD, Bolling SF, George I, et al. Tricuspid Regurgitation. JACC Cardiovasc Imaging. 2019;12(4):605–21.
Addetia K, Muraru D, Veronesi F, Jenei C, Cavalli G, Besser SA, et al. 3-dimensional echocardiographic analysis of the tricuspid annulus provides new insights into tricuspid valve geometry and dynamics. JACC: Cardiovasc Imaging. 2019;12:401–12.
Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Tribouilloy C, Hagendorff A, Monin JL, Badano L, Zamorano JL. European Association of Echocardiography. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr. 2010;11(4):307–32.
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM III, Thomas JD. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation. 2014;129:e521–643.
Hauck AJ, Freeman DP, Ackermann DM, Danielson GK, Edwards WD. Surgical pathology of the tricuspid valve: A study of 363 cases spanning 25 years. Mayo Clin Proc. 1988;63(9):851–63.
Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43(3):405–9.
Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999;83(6):897–902.
Mutlak D, Lessick J, Reisner SA, Aronson D, Dabbah S, Agmon Y. Echocardiography-based spectrum of severe tricuspid regurgitation: the frequency of apparently idiopathic tricuspid regurgitation. J Am Soc Echocardiogr. 2007;20(4):405–8.
He Y, Guo Y, Li Z, Chen J, Kontos MC, Paulsen WHJ, et al. Echocardiographic determination of the prevalence of primary myxomatous degeneration of the cardiac valves. J Am Soc Echocardiogr. 2011;24(4):399–404.
Come PC, Riley MF, Carl LV, Nakao S. Pulsed Doppler echocardiographic evaluation of valvular regurgitation in patients with mitral valve prolapse: comparison with normal subjects. J Am Coll Cardiol. 1986;8(6):1355–64.
van Son JAM, Miles CM, Starr A. Tricuspid valve prolapse associated with myxomatous degeneration. Ann Thorac Surg. 1995;59(5):1237.
Henein MY, O’Sullivan CA, Li W, Sheppard M, Ho Y, Pepper J, et al. Evidence for rheumatic valve disease in patients with severe tricuspid regurgitation long after mitral valve surgery: the role of 3D echo reconstruction. J Heart Valve Dis. 2003;12(5):566.
Bernal JM, Pontón A, Diaz B, Llorca J, García I, Sarralde A, et al. Surgery for rheumatic tricuspid valve disease: A 30-year experience. J Thorac Cardiovasc Surg. 2008;136(2):476–81.
Connolly HM, Pellikka PA. Carcinoid heart disease. Curr Cardiol Rep. 2006;8(2):96–101.
Bhattacharyya S, Davar J, Dreyfus G, Caplin ME. Carcinoid heart disease. Circulation. 2007;116(24):2860–5.
Attenhofer Jost CH, Connolly HM, Dearani JA, Edwards WD, Danielson GK. Ebstein’s anomaly. Circulation. 2007;115(2):277.
Danielson GK, Driscoll DJ, Mair DD, Warnes CA, Oliver WC. Operative treatment of Ebstein’s anomaly. J Thorac Cardiovasc Surg. 1992;104(5):1195–202.
Booker OJ, Nanda NC. Echocardiographic assessment of Ebstein’s anomaly. Echocardiography. 2015;32(S2):S177–88.
Fanari Z, Hammami S, Hammami MB, Hammami S, Shuraih M. The effects of right ventricular apical pacing with transvenous pacemaker and implantable cardioverter defibrillator on mitral and tricuspid regurgitation. J Electrocardiol. 2015;48(5):791–7.
Addetia K, Harb SC, Hahn RT, Kapadia S, Lang RM. Cardiac implantable electronic device lead-induced tricuspid regurgitation. JACC Cardiovasc Imaging. 2019;12(4):622–36.
Mediratta A, Addetia K, Yamat M, Moss JD, Nayak HM, Burke MC, et al. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation. JACC Cardiovasc Imaging. 2014;7(4):337–47.
Seo Y, Ishizu T, Nakajima H, Sekiguchi Y, Watanabe S, Aonuma K. Clinical utility of 3-dimensional echocardiography in the evaluation of tricuspid regurgitation caused by pacemaker leads. Circ J. 2008;72(9):1465–70.
Vaturi M, Kusniec J, Shapira Y, Nevzorov R, Yedidya I, Weisenberg D, et al. Right ventricular pacing increases tricuspid regurgitation grade regardless of the mechanical interference to the valve by the electrode. Eur J Echocardiogr. 2010;11(6):550–3.
Prihadi EA, Delgado V, Leon MB, Enriquez-Sarano M, Topilsky Y, Bax JJ. Morphologic types of tricuspid regurgitation: characteristics and prognostic implications. JACC Cardiovasc Imaging. 2019;12(3):491–9.
Bartko PE, Arfsten H, Frey MK, Heitzinger G, Pavo N, Cho A, et al. Natural history of functional tricuspid regurgitation: implications of quantitative Doppler assessment. JACC Cardiovasc Imaging. 2019;12(3):389–97.
Bustamante-Labarta M, Perrone S, de la Fuente RL, Stutzbach P, de la Hoz RP, Torino A, et al. Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension. J Am Soc Echocardiogr. 2002;15(10):1160–4.
Utsunomiya H, Itabashi Y, Mihara H, Berdejo J, Kobayashi S, Siegel RJ, et al. Functional tricuspid regurgitation caused by chronic atrial fibrillation: a real-time 3-dimensional transesophageal echocardiography study. Circ Cardiovasc Imaging. 2017;10(1):e004897.
Topilsky Y, Nkomo VT, Vatury O, Michelena HI, Letourneau T, Suri RM, et al. Clinical outcome of isolated tricuspid regurgitation. J Am Coll Cardiol Img. 2014;7(12):1185–94.
Fender EA, Zack CJ, Nishimura RA. Isolated tricuspid regurgitation: outcomes and therapeutic interventions. Heart. 2018;104(10):798–806.
Hahn RT, Delhaas T, Denti P, Waxman AB. The tricuspid valve relationship with the right ventricle and pulmonary vasculature. J Am Coll Cardiol Img. 2019;12(3):559–71.
Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation. J Am Soc Echocardiogr. 2017;30(4):303–71.
Hahn RT, Thomas JD, Khalique OK, Cavalcante JL, Praz F, Zoghbi WA. Imaging assessment of tricuspid regurgitation severity. J Am Coll Cardiol Img. 2019;12(3):469–90.
Thomas JD, Liu CM, Flachskampf FA, O’Shea JP, Davidoff R, Weyman AE. Quantification of jet flow by momentum analysis. An in vitro color Doppler flow study. Circulation. 1990;81(1):247.
Song JM, Jang MK, Choi YS, Kim YJ, Min SY, Kim DH, et al. The vena contracta in functional tricuspid regurgitation: a real-time three-dimensional color Doppler echocardiography study. J Am Soc Echocardiogr. 2011;24(6):663–70.
Hahn RT, Zamorano JL. The need for a new tricuspid regurgitation grading scheme. Eur Heart J Cardiovasc Imaging. 2017;18(12):1342–3.
Waller BF. Pathology of TS and TR (Part III). Clin Cardiol. 1995;18(4):225–30. https://pubmed.ncbi.nlm.nih.gov/7788951/.
Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr. 2009;10(1):1–25.
Zoghbi WA, Chambers JB, Dumesnil JG, Foster E, Gottdiener JS, Grayburn PA, et al. Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound. A report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Task Force on prosthetic valves, developed in conjunction. J Am Soc Echocardiogr. 2009;22(9):975–1014.
Blauwet LA, Danielson GK, Burkhart HM, Dearani JA, Malouf JF, Connolly HM, et al. Comprehensive echocardiographic assessment of the hemodynamic parameters of 285 tricuspid valve bioprostheses early after implantation. J Am Soc Echocardiogr. 2010;23(10):1045–59.e2.
Blauwet LA, Burkhart HM, Dearani JA, Malouf JF, Connolly HM, Hodge DO, et al. Comprehensive echocardiographic assessment of mechanical tricuspid valve prostheses based on early post-implantation echocardiographic studies. J Am Soc Echocardiogr. 2011;24(4):414–24.
Zoghbi WA, Asch FM, Bruce C, Gillam LD, Grayburn PA, Hahn RT, et al. Guidelines for the evaluation of valvular regurgitation after percutaneous valve repair or replacement: a report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Angiography and Interventions, Japanese Society of Echocardiography, and Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2019;32(4):431–75.
Nickenig G, Kowalski M, Hausleiter J, Braun D, Schofer J, Yzeiraj E, et al. Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge MitraClip technique. Circulation. 2017;135(19):1802–14.
Pozzoli A, Elisabetta L, Vicentini L, Alfieri O, De Bonis M. Surgical indication for functional tricuspid regurgitation at initial operation: judging from long term outcomes. Gen Thorac Cardiovasc Surg. 2016;64(9):509–16.
Demir OM, Regazzoli D, Mangieri A, Ancona MB, Mitomo S, Weisz G, et al. Transcatheter tricuspid valve replacement: principles and design. Front Cardiovasc Med. 2018;5:129.
Prihadi EA, Delgado V, Hahn RT, Leipsic J, Min JK, Bax JJ. Imaging needs in novel transcatheter tricuspid valve interventions. JACC Cardiovasc Imaging. 2018;11(5):736–54.
Asmarats L, Puri R, Latib A, Navia JL, Rodés-Cabau J. Transcatheter tricuspid valve interventions: landscape, challenges, and future directions. J Am Coll Cardiol. 2018;71(25):2935–56.
Vismara R, Gelpi G, Prabhu S, Romitelli P, Troxler LG, Mangini A, Romagnoni C, Contino M, Van Hoven DT, Lucherini F, Jaworek M, Redaelli A, Fiore GB, Antona C. Transcatheter edge-to-edge treatment of functional tricuspid regurgitation in an ex vivo pulsatile heart model. J Am Coll Cardiol. 2016;68(10):1024–33.
Taramasso M, Alessandrini H, Latib A, Asami M, Attinger-Toller A, Biasco L, et al. Outcomes after current transcatheter tricuspid valve intervention. JACC: Cardiovasc Interv. 2019;12(2):155–65.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic Supplementary Material
Video 5.1a
Tricuspid valve prolapse. Left: Right ventricular parasternal inflow view showing prolapse and billowing of the septal leaflet. Right: Zoomed right ventricular parasternal inflow view with Color Doppler showing eccentric jet away from the prolapsed leaflet (MP4 981 kb)
Video 5.1b
Rheumatic heart disease. Apical four-chamber view showing thickening and restriction of the tricuspid leaflets as well as annular dilation and an enlarged large RA. There is also significant RV dilation and tethering of the tricuspid leaflets in the setting of pulmonary hypertension leading to a large coaptation gap between tricuspid leaflets. This patient also has severe mitral and aortic stenosis in the setting of rheumatic heart disease (AVI 29086 kb)
Video 5.1c
Carcinoid. Left: Right ventricular parasternal inflow view showing reduced mobility of the tricuspid valve in a patient with carcinoid tricuspid valve disease. Right: Diastolic color flow acceleration through the tricuspid valve (MP4 265 kb)
Video 5.1d
Ebstein’s anomaly. Apical four-chamber view showing severe apical displacement of the septal leaflet of the tricuspid valve and right-sided chamber dilation (MP4 1029 kb)
Video 5.2
Tricuspid regurgitation from cardiac electronic device lead impingement. Orthogonal transgastric views of the tricuspid valve. A cardiac electronic device lead is seen tethering the posterior leaflet and contributing to severe tricuspid regurgitation (MP4 502 kb)
Video 5.3a
Secondary tricuspid regurgitation examples. Tricuspid regurgitation due to pulmonary hypertension. Note the tethering of the tricuspid leaflets and lack of significant annular dilation leading to severe tricuspid regurgitation, with the origin of the color jet well below the annular plane (MP4 380 kb)
Video 5.3b
Secondary tricuspid regurgitation examples. Tricuspid regurgitation due to arrhythmogenic right ventricular cardiomyopathy. Left: Transgastric view of the tricuspid valve during early systole. Right: Orthogonal view across the posterior and anterior leaflets. This patient has severe RV dysfunction and torrential tricuspid regurgitation, with a significant tenting area and flail gap (MP4 922 kb)
Video 5.3c
Secondary tricuspid regurgitation examples. Idiopathic tricuspid regurgitation. Right ventricular focused apical four-chamber view in early systole showing severe RV enlargement, tricuspid annular dilation, and tricuspid leaflet malcoaptation. This patient has idiopathic tricuspid regurgitation from atrial fibrillation (MP4 511 kb)
Video 5.4
Features of severe TR. Apical four-chamber view with color Doppler showing severe tricuspid regurgitation (MP4 733 kb)
Video 5.5
Prosthetic tricuspid stenosis. Zoomed apical four-chamber TTE view showing color flow acceleration across a 31-mm St. Jude tricuspid prosthetic valve during diastole, consistent with tricuspid stenosis (MP4 482 kb)
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Nguyen, T.D., Wong, J.M., Abouzeid, C., Qasim, A.N. (2022). Echocardiographic Assessment of Tricuspid Valve Disease. In: Mathelier, H., Lilly, S.M., Shreenivas, S. (eds) Tricuspid Valve Disease. Contemporary Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-030-92046-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-92046-3_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-92045-6
Online ISBN: 978-3-030-92046-3
eBook Packages: MedicineMedicine (R0)